Jeremy Hoog

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

3.4Author DataRank

Indexed papers

7in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 7 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Nature Communications(2021)10.1038/s41467-021-25177-3

Top 8%

2.7DataRank

Top 8%109 citations

Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl +94 more

Papers

Driven by 35 papers — median percentile 0. Top paper: “Proteogenomic integration reveals therapeutic targets in breast cancer xenografts”.

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

Nature Communications(2017)10.1038/ncomms14864

N/A

4.9DataRank · unranked

155 citations

Shunqiang Li, Philipp Mertins, Song Cao, Harsha P. Gunawardena, Kelly V. Ruggles +40 more

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Nature Communications(2021)10.1038/s41467-021-25177-3

Top 8%

2.7DataRank

Top 8%109 citations

Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl +94 more

Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0200

N/A

2.5DataRank · unranked

140 citations

Eric J. Jaehnig, Karsten Krug, Jonathan T. Lei, Erik J. Bergstrom, Beom-Jun Kim +34 more

Correction: Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

Nature Communications(2017)10.1038/ncomms15479

N/A

0.843DataRank · unranked

11 citations

Shunqiang Li, Philipp Mertins, Song Cao, Harsha P. Gunawardena, Kelly V. Ruggles +40 more

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor–Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination

JAMA Oncology(2024)10.1001/jamaoncol.2023.6038

N/A

0.819DataRank · unranked

21 citations

Vera J. Suman, Souzan Sanati, Kiran Vij, Meenakshi Anurag, A. Marilyn Leitch +25 more

Microscaled proteogenomic methods for precision oncology

Nature Communications(2020)10.1038/s41467-020-14381-2

N/A

0.722DataRank · unranked

122 citations

Eric J. Jaehnig, Karsten Krug, Beom‐Jun Kim, Alexander B. Saltzman, Doug W. Chan +28 more

A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)

npj Breast Cancer(2023)10.1038/s41523-022-00504-z

N/A

0.705DataRank · unranked

23 citations

Donald W. Northfelt, Tracey L. O’Connor, Ellis Levine, Jingqin Luo, Yu Tao +16 more

PDXNet portal: patient-derived Xenograft model, data, workflow and tool discovery

NAR Cancer(2022)10.1093/narcan/zcac014

Top 31%

0.652DataRank

Top 31%22 citations

Michael W. Lloyd, Jeffrey W. Grover, Nan Xiao, Sara Seepo, Sai Lakshmi Subramanian +95 more

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

UNC Libraries(2020)10.17615/0xdg-yq72

N/A

0.552DataRank · unranked

6 citations

Shunqiang Li, Philipp Mertins, Song Cao, Harsha P. Gunawardena, Kelly V. Ruggles +40 more

Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1

Cell Reports(2021)10.1016/j.celrep.2021.108749

N/A

0.483DataRank · unranked

24 citations

Sun-Joong Kim, Arshag D. Mooradian, Faliang Wang, Ziqian Li, Sean Holohan +9 more

Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models

UNC Libraries(2020)10.17615/zy2g-ye61

N/A

0.449DataRank · unranked

19 citations

Christine E. Ryan, Aleix Prat, Zhanfang Guo, Matthew J. Ellis, W. Timothy Schaiff +8 more

Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models

Cancers(2020)10.3390/cancers12123857

N/A

0.396DataRank · unranked

13 citations

Tina Primeau, Jingqin Luo, Cynthia Zhang, Hua Sun, Jeremy Hoog +10 more

Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0047

N/A

0.208DataRank · unranked

3 citations

Jingqin Luo, R. Jay Mashl, Jeremy Hoog, Piyush Maiti, Nikki Fettig +11 more

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor–Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination

UNC Libraries(2024)10.17615/41px-cd59

N/A

0.104DataRank · unranked

1 citations

Travis Dockter, Amy Tiersten, Matthew J. Ellis, Kelly K. Hunt, Wajeeha Razaq +25 more

Supplementary Figures from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416134.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Relationship Between Plasma Estradiol Levels and Estrogen-Responsive Gene Expression in Estrogen Receptor–Positive Breast Cancer in Postmenopausal Women

UNC Libraries(2020)10.17615/2dy4-8b47

N/A

0DataRank · unranked

0 citations

Anita K. Dunbier, H Anderson, Elizabeth Folkerd, Charles M. Perou, Roger A’Hern +9 more

Data from PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor–Positive Breast Cancer

(2023)10.1158/0008-5472.c.6499523.v1

N/A

0DataRank · unranked

0 citations

Chanpheng Phommaly, Yu Tao, Jeremy Hoog, Jingqin Luo, Charles M. Perou +12 more

Microscaled proteogenomic methods for precision oncology

UNC Libraries(2024)10.17615/rb11-7v56

N/A

0DataRank · unranked

0 citations

B Zhang, F. O. Ademuyiwa, Prashant R. Singh, Charles M. Perou, Alexander B. Saltzman +28 more

Supplementary Figure S3 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models

10.1158/2767-9764.25976510

Top 100%

0DataRank

Top 100%0 citations

Jingqin Luo, R. Jay Mashl, Jeremy Hoog, Piyush Maiti, Nicole Fettig +11 more

FIGURE 3 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models

10.1158/2767-9764.25976528

N/A

0DataRank · unranked

0 citations

Jingqin Luo, R. Jay Mashl, Jeremy Hoog, Piyush Maiti, Nicole Fettig +11 more

Supplementary File 5 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416119.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary Figure S1 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models

10.1158/2767-9764.25976516

N/A

0DataRank · unranked

0 citations

Jingqin Luo, R. Jay Mashl, Jeremy Hoog, Piyush Maiti, Nicole Fettig +11 more

Supplementary File 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416128.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 4 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416122

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary tables 1 and 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416116

Top 100%

0DataRank

Top 100%0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Data from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.c.6509465.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary Figures from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416134

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 1 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416131.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 5 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416119

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary tables 1 and 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416116.v1

Top 100%

0DataRank

Top 100%0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Data from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.c.6509465

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Extended Methods from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416140

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416128

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 4 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416122.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Extended Methods from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416140.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Jeremy Hoog

Indexed papers

Top data-sharing exemplar

Papers